Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens

BACKGROUND: High-risk human papillomavirus (HR HPV) testing is already part of cervical cancer screening programs in a number of countries. New tests need to be validated not only in clinical studies but also in routine screening settings with regard to their clinical performance. METHODS: The Abbot...

Descripción completa

Detalles Bibliográficos
Autores principales: Iftner, Thomas, Wang, Lisa, Iftner, Angelika, Holz, Barbara, Haedicke-Jarboui, Juliane, Iftner, Nathalie, von Wasielewski, Reinhard, Martus, Peter, Boehmer, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106810/
https://www.ncbi.nlm.nih.gov/pubmed/27835974
http://dx.doi.org/10.1186/s12879-016-1994-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106810/
https://www.ncbi.nlm.nih.gov/pubmed/27835974
http://dx.doi.org/10.1186/s12879-016-1994-0

Ejemplares similares